Form 4 for ACXP Acurx Pharmaceuticals, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2021-12-02 · accession 0001104659-24-001375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-04 | 2021-12-02+ | ACXP | DELUCCIA ROBERT J | Dir, 10% | G - Gift | $0.00 | -110.0K | 941.2K | -10% | $0 |
| D | 2024-01-04 | 2024-01-03 | ACXP | DELUCCIA ROBERT J | Dir, 10% | M - OptEx | $3.55 | +19.7K | 960.9K | +2% | +$70.1K |
| D | 2024-01-04 | 2024-01-03 | ACXP | DELUCCIA ROBERT J | Dir, 10% | M - OptEx | $0.00 | -19.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | G | D | 40,000 | $0.00 | 1,011,198 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-12 | G | D | 40,000 | $0.00 | 971,198 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-22 | G | D | 30,000 | $0.00 | 941,198 | D | — | — | |
| 4 | Common | Common Stock | 2024-01-03 | M | A | 19,737 | $3.55 | 960,935 | D | — | — | |
| 5 | Derivative | Warrants for Common Stock | 2024-01-03 | M | D | 19,737 | $0.00 | 0 | D | $3.55 · 2023-01-27 to 2024-01-27 | 19,737 Common Stock |